Opus Genetics

Developer of gene therapies to treat retinal degenerative diseases

placeDurham, North Carolina, United States calendar_todayFounded 2021 groups14 employees language opusgtx.com

Registered entities

Innovation

10 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 3,268 times.

YearFilings
20242
20258
20263

Investor mix

4 investors on record; lead investors include RD Fund.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

11 Mar 2026 · Director Process Development and Manufacturing, CMC · Durham

5 Oct 2025 · Senior Director Quality Assurance · Durham

Based on job postings tracked across public sources.

Coming soon